Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.103
Bid: 0.098
Ask: 0.103
Change: 0.0015 (1.52%)
Spread: 0.005 (5.102%)
Open: 0.103
High: 0.103
Low: 0.103
Prev. Close: 0.099
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

10 Jan 2024 11:29

RNS Number : 2717Z
Versarien PLC
10 January 2024
 

10 January 2024

Versarien Plc

("Versarien" or the "Company")

Result of General Meeting

Versarien Plc (AIM: VRS), the advanced materials engineering group, is pleased to confirm that at the Company's General Meeting held earlier today, all resolutions were duly passed. Full details of the resolutions are set out in the Notice of General Meeting dated 20 December 2023 and available on the Company's website at: https://www.versarien.com/investors/reports-and-presentations/

The proxy votes cast were as follows:

Resolution

 

For

 

 

Against

 

 

Abstain

1 - to sub-divide each Existing

Ordinary Share into one New Ordinary Share and one New Deferred Share

 

22,939,297

93.25%

1,661,734

6.75%

303,606

2 - a special resolution to alter the Articles to allow for the issue of New Deferred Shares by including provisions relating to the rights and restrictions attached to the New Deferred Shares

 

22,992,555

93.78%

1,524,588

6.22%

387,494

3 - to grant the directors authority to allot up to 992,339,000 New Ordinary Shares

 

22,754,233

93.16%

1,670,424

6.84%

479,980

4 - a special resolution to grant the directors authority to allot up to 992,339,000 New Ordinary Shares for cash without first offering them to existing shareholders

 

22,530,861

92.30%

1,880,416

7.70%

493,360

 

Share Capital Reorganisation

Following the passing of the resolutions at the General Meeting, each of the Company's 496,169,507 Existing Ordinary Shares will be sub-divided into one New Ordinary Share of 0.01p (the "New Ordinary Shares") and one deferred share of 0.09p ("New Deferred Shares"). The New Deferred Shares will have little economic value as they will not carry any rights to vote or dividend rights, although the New Deferred Shares will rank pari passu with the New Ordinary Shares on a return of capital or on a winding up of the Company.

 

Admission to AIM and Total Voting Rights

Dealings on AIM in the Existing Ordinary Shares is expected to cease at the close of business on 10 January 2024. Application has been made for the admission of 496,169,507 New Ordinary Shares to trading on AIM ("Admission") and it is expected that Admission will take place and that trading in the New Ordinary Shares will commence at 8.00 a.m. on or around 11 January 2024. No application will be made for admission of the New Deferred Shares to trading on AIM nor will any such application be made to any other exchange.

Following Admission, there will be a total of 496,169,507 New Ordinary Shares, with voting rights, in issue. The Company does not hold any shares in treasury. Consequently, 496,169,507 is the figure which may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Unless otherwise indicated, all defined terms in this announcement shall have the same meaning as described in the Company's announcement dated 20 December 2023 and the Circular which was posted to shareholders on the same day.

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

 

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

 

+44 (0)20 3470 0470

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

For further information please see: http://www.versarien.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMGPURPGUPCGGU
Date   Source Headline
19th Oct 20204:41 pmRNSSecond Price Monitoring Extn
19th Oct 20204:35 pmRNSPrice Monitoring Extension
16th Oct 20205:18 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSAdvisory Panel
24th Sep 202012:07 pmRNSResult of AGM
23rd Sep 20207:00 amRNSPosting of Annual Report
1st Sep 20207:00 amRNSNotice of AGM
17th Aug 20207:00 amRNSUpdate re. Innovate UK Loan Agreement
11th Aug 20207:00 amRNSPreliminary Results
3rd Aug 20207:00 amRNSLaunch of Graphene Enhanced Protective Face Mask
1st Jul 20207:01 amRNS£5 million Innovate UK Loan Agreement
1st Jul 20207:00 amRNSCorporate Update and Notice of Results
19th Jun 20207:00 amRNSAppointment of Non-executive Chairman
12th Jun 20209:41 amRNSInvestor Communication
4th Jun 202012:02 pmRNSPrice Monitoring Extension
19th May 202012:07 pmRNSSecond Price Monitoring Extn
19th May 202012:02 pmRNSPrice Monitoring Extension
18th May 20204:41 pmRNSSecond Price Monitoring Extn
18th May 20204:36 pmRNSPrice Monitoring Extension
28th Apr 202011:17 amRNS2-DTech awarded grant
23rd Apr 20207:00 amRNSRolls-Royce chooses to partner with GEIC & 2-DTech
15th Apr 20205:10 pmRNSHolding(s) in Company
6th Apr 20207:00 amRNSClarification: Sharing Agreement & China JV
2nd Apr 20203:32 pmRNSHolding(s) in Company
31st Mar 202012:08 pmRNSSecond Price Monitoring Extn
31st Mar 202012:02 pmRNSPrice Monitoring Extension
31st Mar 20207:00 amRNSTotal Voting Rights
30th Mar 20207:00 amRNSHolding(s) in Company
27th Mar 20202:05 pmRNSSecond Price Monitoring Extn
27th Mar 20202:00 pmRNSPrice Monitoring Extension
26th Mar 202011:05 amRNSSecond Price Monitoring Extn
26th Mar 202011:00 amRNSPrice Monitoring Extension
25th Mar 20202:05 pmRNSSecond Price Monitoring Extn
25th Mar 20202:00 pmRNSPrice Monitoring Extension
25th Mar 202011:05 amRNSSecond Price Monitoring Extn
25th Mar 202011:00 amRNSPrice Monitoring Extension
25th Mar 20207:00 amRNSChina Update
23rd Mar 20203:06 pmRNSInvestor Communications
23rd Mar 20207:00 amRNSSubscription to raise £6 million
4th Mar 20204:40 pmRNSSecond Price Monitoring Extn
4th Mar 20204:35 pmRNSPrice Monitoring Extension
3rd Mar 20204:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20204:36 pmRNSPrice Monitoring Extension
28th Feb 20207:00 amRNSInvestor Communications
26th Feb 202011:05 amRNSSecond Price Monitoring Extn
26th Feb 202011:00 amRNSPrice Monitoring Extension
25th Feb 20201:48 pmRNSCorporate update
18th Feb 20204:15 pmRNSChange of Substantial Shareholding
17th Feb 20207:00 amRNSChange of Nominated Adviser and Broker
12th Feb 20204:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.